X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-17 | UPXI | Marshall Allan | CEO, 10% | P - Purchase | $2.28 | +657,895 | 884,318 | +291% | +$1,500,001 | |||||
2025-04-17 | UPXI | Norstrud Andrew James | CFO | P - Purchase | $2.28 | +43,860 | 159,138 | +38% | +$100,001 | ||||||
| D | 2025-04-17 | UPXI | Salkind Gene | Dir, 10% | P - Purchase | $2.28 | +241,229 | 365,127 | +195% | +$550,002 | |||||
| M | 2024-03-11 | UPXI | Marshall Allan | CEO, 10% | P - Purchase | $0.58 | +77,773 | 2,939,654 | +3% | +$44,739 | |||||
2024-03-05 | UPXI | Marshall Allan | CEO, 10% | P - Purchase | $0.70 | +103,013 | 2,861,881 | +4% | +$72,109 | ||||||
| M | 2023-12-15 | UPXI | Marshall Allan | CEO, 10% | P - Purchase | $0.96 | +12,916 | 2,767,249 | 0% | +$12,340 | |||||
2023-12-07 | UPXI | Marshall Allan | CEO, 10% | P - Purchase | $0.94 | +90,001 | 2,754,333 | +3% | +$84,952 | ||||||
| M | 2023-12-04 | UPXI | Marshall Allan | CEO, 10% | P - Purchase | $0.76 | +53,474 | 2,664,332 | +2% | +$40,652 | |||||
| M | 2023-06-22 | UPXI | Marshall Allan | CEO, 10% | P - Purchase | $2.36 | +79,945 | 2,690,803 | +3% | +$188,783 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |